Screener
Charles River Laboratories CRL Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|
| Deferred revenue | 5,593 | 11,306 |
| Customer contract deposits | (4,543) | 568 |
| Other assets and liabilities, net | (20,335) | (22,208) |
| Net cash provided by operating activities | 220,802 | 376,300 |
| Cash flows relating to investing activities | ||
| Acquisition of businesses and assets, net of cash acquired | (467,254) | — |
| Capital expenditures | (87,013) | (94,622) |
| Purchases of investments and contributions to venture capital investments | (11,805) | (8,090) |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's operating cash flow?
- Charles River Laboratories (CRL) reported operating cash flow of $179.73M in Q2 2026.
- How has Charles River Laboratories's operating cash flow changed year-over-year?
- Charles River Laboratories's operating cash flow decreased by 12.2% year-over-year, from $204.6M to $179.73M.
- What is the long-term trend for Charles River Laboratories's operating cash flow?
- Over 4 years (2021 to 2025), Charles River Laboratories's operating cash flow has grown at a -0.8% compound annual growth rate (CAGR), from $760.8M to $737.65M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Charles River Laboratories's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude